Quanterix Corporation
Industry / private company
Location:
Lexington, MA,
United States (USA) (US)
ISNI: 0000000405928481
ROR: https://ror.org/02c13hn95
Show on Map:
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 (2021)
Kraemer B, Knoll R, Bonaguro L, Tovinh M, Raabe J, Astaburuaga-Garcia R, Schulte-Schrepping J, et al.
Journal article
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic (2017)
O'Bryant SE, Mielke MM, Rissman RA, Lista S, Vanderstichele H, Zetterberg H, Lewczuk P, et al.
Journal article
Assessing the commutability of reference material formats for the harmonization of amyloid-? measurements (2016)
Bjerke M, Andreasson U, Kuhlmann J, Portelius E, Pannee J, Lewczuk P, Umek RM, et al.
Journal article
Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases (2015)
Lleo A, Cavedo E, Parnetti L, Vanderstichele H, Herukka SK, Andreasen N, Ghidoni R, et al.
Journal article